PRCT:NASDAQ, PROCEPT BioRobotics Corporation
PRCT stock overview
PROCEPT BioRobotics Corporation (PRCT:NASDAQ) closed at $24.70 on November 20, 2026,
down 4.08% on the day.
The stock trades 35.2% below its 52-week high of $38.11
and 48.2% above its 52-week low of $16.67.
Over the past year, it lost 17.7%.
PROCEPT BioRobotics Corporation is part of the Health Care sector.
Key figures
- Price
- $24.70
- Day change
- -4.08%
- Volume
- 1,037,512
- Average volume
- 1,303,957
- Market cap
- 1B+
- 52-week range
- $16.67 – $38.11
- 50-day average
- $19.78
- 200-day average
- $22.82
Price action over the past year
In 252 trading sessions since November 20, 2025, PRCT closed higher on 124 days (49%).
Its best day was March 11, 2026 (+15.02%) and its worst was February 26, 2026 (-15.12%).
The stock moved 10% or more in a single session 7 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
PRCT news
-
Nov 18, 2026:
PROCEPT BioRobotics to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
-
Nov 18, 2026:
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
-
Nov 13, 2026:
PROCEPT BioRobotics (PRCT) Stock Looks Overvalued Against Its Sales Story
-
Nov 6, 2026:
PROCEPT BioRobotics (PRCT) Stock Dropped, So What Is Driving Attention Now?
-
Nov 5, 2026:
PROCEPT BioRobotics Corporation Q3 2026 Earnings Call Summary
-
Nov 5, 2026:
PROCEPT BioRobotics Corp (PRCT) (Q3 2026) Earnings Call Highlights: Revenue Grows 18% as Hydros ...
-
Nov 5, 2026:
PROCEPT BioRobotics Q3 Earnings Call Highlights
-
Nov 5, 2026:
PROCEPT BioRobotics Misses As U.S. Procedures Stall Sequentially, Leaving A Steep Fourth Quarter To Carry Its Reaffirmed Guidance
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
Similar stocks
Find more stocks like PRCT with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.